Assessment of inflammatory markers and their association with disease mortality in severe COVID-19 patients of tertiary care hospital in South India

被引:6
|
作者
Devang, Nayana [1 ]
Sreelatha, Souparnika [2 ]
Mamatha, B., V [1 ]
机构
[1] Kanachur Inst Med Sci & Res Ctr, Dept Biochem, Mangalore Univ Rd, Mangaluru 575018, Karnataka, India
[2] NITTE Univ, KS Hegde Med Acad, Dept Biochem, Mangaluru 575018, Karnataka, India
关键词
COVID-19; Inflammation; C-reactive protein; Lactate dehydrogenase; Ferritin; Oxygen saturation; Mortality; LACTATE-DEHYDROGENASE;
D O I
10.1186/s43168-022-00159-1
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: COVID-19 infection involves a complex interplay of the immunological and inflammatory responses. Low blood-oxygen levels have been a hallmark in COVID-19 patients. The lung tissue damage infiltered by the viral-mediated inflammation decreases oxygen saturation to cause silent hypoxia and cell death. This study aimed to evaluate the association of inflammatory biomarkers with oxygen saturation (SpO(2)) and mortality in severe COVID-19 patients. Methods: A total of 190 severe COVID-19 patients were included in this study after confirmed by the RT-PCR assay. The laboratory tests were performed for biochemical assessment. Serum levels of C-reactive protein (CRP), lactate dehydrogenase (LDH), and ferritin were determined and compared between survivors and nonsurvivors using independent sample t-test. The correlation of these inflammatory markers was studied using Spearman's correlation, and their association with mortality was studied using logistic regression. Results: All the COVID-19 patients were severe with SpO(2)< 90% and respiratory rate > 30/min. While the serum levels of CRP, LDH, ferritin, aspartate transaminase (AST), urea, and random blood sugar (RBS) were elevated, hemoglobin (Hb) and SpO(2) levels were reduced in COVID-19 patients. LDH and ferritin levels were significantly higher in nonsurvivors compared to survivors with p values of 0.001 and 0.022 respectively. Spearman's correlation showed a significant correlation of the inflammatory markers with SpO(2), serum electrolytes (potassium, chloride), liver enzymes (AST and alanine transaminase (ALT)), and markers of kidney damage (urea, creatinine). Conclusion: Inflammatory markers could effectively discriminate the risk of mortality in severe COVID-19 patients. As CRP, LDH, and ferritin levels determine the tissue oxygen availability, they seem to be valuable biomarkers in the prognosis of COVID-19.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Association of Inflammatory Markers With Disease Progression and the Severity of COVID-19
    Patel, Stuti V.
    Pathak, Jaya M.
    Parikh, Radhay J.
    Pandya, Karan J.
    Kothari, Priyal B.
    Patel, Arushi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [32] Assessment of the effectiveness of tocilizumab on mortality and progression to mechanical ventilation or intensive care in patients with COVID-19 admitted to a tertiary hospital
    Pinilla Rello, Andrea
    Magallon Martinez, Arantxa
    Vicente Iturbe, Cristina
    Escolano-Pueyo, Angel
    Herranz Bayo, Elena
    Aguilo Lafarga, Irene
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024, 31 (03) : 212 - 219
  • [33] COVID-19 pandemic: Hospital preparedness in a tertiary care hospital in North East India
    Pandita, Kawal Krishan
    Noor, Topno
    Sahoo, Sambit Kumar
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (06) : 2877 - 2883
  • [34] Epidemiology of hospitalized patients with COVID-19 in a tertiary care hospital
    Maza-De la Torre, Guadalupe
    Montelongo-Mercado, Edgardo A.
    Noyola-Villalobos, Hector F.
    Garcia-Ruiz, Antonio
    Hernandez-Diaz, Sergio
    Santiago-Torres, Martha
    Moreno-Delgado, Luis F.
    Carrera-Altamirano, Ricardo
    Munoz-Monroy, Omar E.
    Martinez-Cuazitl, Adriana
    Martinez-Gonzalez, Mayra A.
    Vazquez-Medina, Martin U.
    Alvarado-Uribe, Oscar
    Torres-Vazquez, Julian
    Figueroa-Pena, Aldo
    Martinez-Salazar, Ivan N.
    GACETA MEDICA DE MEXICO, 2021, 157 (03): : 246 - 254
  • [35] Management of glaucoma patients at a tertiary care hospital during the COVID-19 pandemic in Western India
    Bhatnagar, Kavita R.
    Shakrawal, Jyoti
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (05) : 2306 - 2307
  • [36] ASSOCIATION BETWEEN BMI AND INFLAMMATORY MARKERS IN COVID-19 PATIENTS
    Mendez-Castro, Jesus
    Castro, Juan ManuelMendez
    Mariana Ramirez, Luz
    Said, Mohamed Ziad-M.
    Villalobos, Ana
    Molina, Paloma
    Texidor, Jovana
    Terrazas, Andrea
    Canto-Costal, Ana Cecilia
    Mongo, Joel
    Mathew, Joan
    Patron, Daniel
    Aguilar, Isaac
    Figueroa, Rene
    Sammyghaou
    Josephvaron
    CRITICAL CARE MEDICINE, 2024, 52
  • [37] Epidemiological and clinical profile of COVID-19 patients admitted in a tertiary care hospital in Western India
    Jain, Shikha
    Raval, Devang
    Mitra, Aarohi
    Chaudhary, Diksha
    Khare, Utkarsh
    INDIAN JOURNAL OF COMMUNITY MEDICINE, 2022, 47 (01) : 138 - 141
  • [38] Epidemiological Profile and Clinical Outcome of COVID-19 Patients in a Tertiary Care Hospital, Pune, India
    Sondankar, Prachi D.
    Agawane, Shubhangi U.
    Mane, Abhay B.
    Chawla, Parvinder S.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (07)
  • [39] Predictors of early death in patients with COVID-19 pneumonia in a tertiary-care hospital in India
    Nair, P. Ramachandran
    Damarla, H.
    Ray, B.
    Anand, R.
    Maitra, S.
    Baidya, D.
    ANAESTHESIA, 2021, 76 : 83 - 83
  • [40] Assessment of the Impact of COVID-19 on Drug Store Management in a Tertiary Care Teaching Hospital of Central India
    Padhan, Srikanta
    Pugazhenthan, T.
    Chandrakar, Ramesh
    Galhotra, Abhiruchi
    Borkar, Nitinkumar B.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)